Valuation : PeptiDream Inc.

Market Cap 141B 914M 786M 739M 675M 1.26B 86.63B 1.27B 8.76B 3.39B 44.28B 3.43B 3.36B P/E 2026 *
21x
P/E 2027 * 15.1x
Enterprise Value 128B 828M 712M 670M 612M 1.14B 78.54B 1.15B 7.94B 3.07B 40.14B 3.11B 3.04B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 2.96x
Free-Float
72.25%
Yield 2026 *
-
Yield 2027 * 0.36%
1 day-1.23%
1 week+0.65%
Current month-0.69%
1 month+9.10%
3 months+8.09%
6 months-25.78%
Current year-34.65%
1 week 1,056.5
Extreme 1056.5
1,112
1 month 972.5
Extreme 972.5
1,155
Current year 906.4
Extreme 906.4
1,788
1 year 906.4
Extreme 906.4
1,793
3 years 906.4
Extreme 906.4
3,060
5 years 906.4
Extreme 906.4
4,005
10 years 906.4
Extreme 906.4
6,540
Manager TitleAgeSince
Chief Executive Officer 51 01/01/2022
Chief Operating Officer - 02/07/2026
Chief Tech/Sci/R&D Officer - 01/04/2024
Director TitleAgeSince
Director/Board Member 51 01/08/2008
Director/Board Member 51 01/09/2017
Director/Board Member 55 01/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.23%+0.65%-37.05%-35.18% 914M
+2.02%+1.26%+41.37%+105.18% 69.19B
-2.10%-5.86%+29.87%+72.42% 62.97B
-1.11%+2.78%-14.86%+375.59% 27.27B
-4.92%-3.22%-3.90%-17.87% 24.78B
-0.93%-0.81%+29.69%+14.38% 25.8B
-0.53%-1.24%+22.11%-17.13% 20.11B
+6.04%+7.25%+233.25%+383.12% 18.47B
-1.43%-2.43%-8.12%+515.88% 14.88B
-2.27%+1.37%+53.01%+160.83% 14.29B
Average -0.27%+0.64%+34.54%+155.72% 27.87B
Weighted average by Cap. -0.25%+0.11%+37.19%+138.81%

Financials

2026 *2027 *
Net sales 36.04B 234M 201M 189M 173M 322M 22.16B 324M 2.24B 867M 11.33B 878M 859M 41.41B 269M 231M 217M 198M 370M 25.46B 372M 2.57B 996M 13.01B 1.01B 986M
Net income 6.77B 43.88M 37.73M 35.49M 32.39M 60.45M 4.16B 60.76M 421M 163M 2.13B 165M 161M 9.39B 60.87M 52.34M 49.24M 44.93M 83.85M 5.77B 84.29M 583M 226M 2.95B 229M 224M
Net Debt -13.16B -85.37M -73.4M -69.06M -63.02M -118M -8.09B -118M -818M -317M -4.14B -321M -314M -18.42B -119M -103M -96.62M -88.18M -165M -11.32B -165M -1.14B -443M -5.79B -449M -439M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
763
Date Price Change Volume
09/09/26 ¥1,082.50 -1.23% 781,800
08/09/26 ¥1,096.00 +0.69% 829,800
07/09/26 ¥1,088.50 +1.82% 544,100
04/09/26 ¥1,069.00 -2.64% 733,500
03/09/26 ¥1,098.00 +2.09% 550,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,096.00JPY
Average target price
2,608.33JPY
Spread / Average Target
+137.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!